Live from the NIH registry
Studies recruiting near Salt Lake City right now
Top 25 of 1,145 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Utah Cancer Specialists-Salt Lake City — Salt Lake City, Utah (2.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Primary Children's Hospital — Salt Lake City, Utah (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Utah, PLLC — Salt Lake City, Utah (2.4 mi)
· Sponsor: Genentech, Inc.
RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
Atrial Fibrillation Paroxysmal
Phase 2
Interventional 78 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10305, Layton, UT — Layton, Utah (19.6 mi)
· Sponsor: Colorado Prevention Center
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Highland Clinical Research /ID# 270281 — Salt Lake City, Utah (2.4 mi)
· Sponsor: AbbVie
Precision Genomics Medicine Biobank
Any Disease Condition and Reportedly-healthy Subjects
N/A
Observational 100,000 participants sought
Intermountain Healthcare — Murray, Utah (8.0 mi)
· Sponsor: Intermountain Health Care, Inc.
Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
Lifestyle Factors, Overweight and Obesity
N/A
Interventional 70 participants sought
College of Health Research Complex--University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
University of Utah Healthcare — Salt Lake City, Utah (2.4 mi)
· Sponsor: Joseph Broderick, MD
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-013 — Layton, Utah (19.6 mi)
· Sponsor: Biohaven Therapeutics Ltd.
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Utah Cancer Specialists — Salt Lake City, Utah (2.4 mi)
· Sponsor: Guardant Health, Inc.
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — West Jordan, Utah (11.6 mi)
· Sponsor: AstraZeneca
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Phase 1, Phase 2
Interventional 460 participants sought
START Mountain Region ( Site 0008) — West Valley City, Utah (7.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
University of Utah Health — Salt Lake City, Utah (2.4 mi)
· Sponsor: Takeda
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
Preterm Delivery, Obstetrical Complications
Phase 3
Interventional 1,800 participants sought
University of Utah Medical Center — Salt Lake City, Utah (2.4 mi)
· Sponsor: The George Washington University Biostatistics Center
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Huntsman Cancer Institute — Salt Lake City, Utah (2.4 mi)
· Sponsor: Pfizer
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — West Valley City, Utah (7.0 mi)
· Sponsor: Avenzo Therapeutics, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Nurix Therapeutics, Inc.
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
Cancer, Smoking
N/A
Interventional 100 participants sought
Huntsman Cancer Institute — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Utah
Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis
Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring, Fragility Fracture
N/A
Interventional 48 participants sought
University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: University of Southern California
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Adult Cystic Fibrosis Center at the University of Utah — Salt Lake City, Utah (2.4 mi)
· Sponsor: Nicole Hamblett
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
Venous Thromboembolic Disease, Pulmonary Embolism and Thrombosis
N/A
Interventional 152,000 participants sought
Intermountain Medical Center — Murray, Utah (8.0 mi)
· Sponsor: Scott C. Woller, MD